Dicot Pharma to outline Phase 2b trial design for LIB-01 at Oct. 13 webcast

Dicot Pharma scheduled an Oct. 13 webcast to recap clinical findings on LIB-01 from an Oct. 8-11 medical meeting and to outline a Phase 2b trial design tailored to LIB-01’s durable pharmacodynamic profile.